Your browser doesn't support javascript.
loading
Unsupervised machine learning highlights the challenges of subtyping disorders of gut-brain interaction.
Dowrick, Jarrah M; Roy, Nicole C; Bayer, Simone; Frampton, Chris M A; Talley, Nicholas J; Gearry, Richard B; Angeli-Gordon, Timothy R.
Afiliação
  • Dowrick JM; Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand.
  • Roy NC; High-Value Nutrition National Science Challenge, Auckland, New Zealand.
  • Bayer S; High-Value Nutrition National Science Challenge, Auckland, New Zealand.
  • Frampton CMA; Department of Human Nutrition, University of Otago, Dunedin, New Zealand.
  • Talley NJ; Riddet Institute, Massey University, Palmerston North, New Zealand.
  • Gearry RB; High-Value Nutrition National Science Challenge, Auckland, New Zealand.
  • Angeli-Gordon TR; Department of Medicine, University of Otago, Christchurch, New Zealand.
Neurogastroenterol Motil ; : e14898, 2024 Aug 09.
Article em En | MEDLINE | ID: mdl-39119757
ABSTRACT

BACKGROUND:

Unsupervised machine learning describes a collection of powerful techniques that seek to identify hidden patterns in unlabeled data. These techniques can be broadly categorized into dimension reduction, which transforms and combines the original set of measurements to simplify data, and cluster analysis, which seeks to group subjects based on some measure of similarity. Unsupervised machine learning can be used to explore alternative subtyping of disorders of gut-brain interaction (DGBI) compared to the existing gastrointestinal symptom-based definitions of Rome IV.

PURPOSE:

This present review aims to familiarize the reader with fundamental concepts of unsupervised machine learning using accessible definitions and provide a critical summary of their application to the evaluation of DGBI subtyping. By considering the overlap between Rome IV clinical definitions and identified clusters, along with clinical and physiological insights, this paper speculates on the possible implications for DGBI. Also considered are algorithmic developments in the unsupervised machine learning community that may help leverage increasingly available omics data to explore biologically informed definitions. Unsupervised machine learning challenges the modern subtyping of DGBI and, with the necessary clinical validation, has the potential to enhance future iterations of the Rome criteria to identify more homogeneous, diagnosable, and treatable patient populations.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article